Getagraph.com logo
S&P 500
(1.26%) 5 127.79 points
Dow Jones
(1.18%) 38 676 points
Nasdaq
(1.99%) 16 156 points
Oil
(-1.22%) $77.99
Gas
(5.65%) $2.15
Gold
(0.02%) $2 310.10
Silver
(-0.16%) $26.79
Platinum
(0.37%) $966.20
USD/EUR
(-0.35%) $0.929
USD/NOK
(-1.07%) $10.87
USD/GBP
(-0.11%) $0.797
USD/RUB
(0.35%) $91.45

Sanntidsoppdatering for Milestone Pharmaceuticals [MIST]

Børs: NASDAQ Sektor: Healthcare Industri: Biotechnology
Upcoming Earnings Alert

5 days till quarter result
(bmo 2024-05-09)

Expected move: +/- 10.55%

Sist oppdatert3 mai 2024 @ 22:00
25% discount on Stockinvest.us - Use code: Podcast

1.81% $ 1.690

Live Chart Being Loaded With Signals

Commentary (3 mai 2024 @ 22:00):
Profile picture for Milestone Pharmaceuticals Inc

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate...

Stats
Dagens volum 85 271.00
Gjennomsnittsvolum 330 017
Markedsverdi 89.82M
EPS $0 ( 2024-04-03 )
Neste inntjeningsdato ( $-0.260 ) 2024-05-09
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -1.220
ATR14 $0.00800 (0.47%)
Insider Trading
Date Person Action Amount type
2023-06-07 Wills Robert James Buy 30 000 Stock Option (right to buy)
2023-06-07 Tomsicek Michael John Buy 30 000 Stock Option (right to buy)
2023-06-07 Pasternak Richard C Buy 30 000 Stock Option (right to buy)
2023-06-07 Liebert Debra K. Buy 30 000 Stock Option (right to buy)
2023-06-07 Giles Lisa M. Buy 30 000 Stock Option (right to buy)
INSIDER POWER
2.10
Last 95 transactions
Buy: 18 033 611 | Sell: 4 881 578

Volum Korrelasjon

Lang: -0.02 (neutral)
Kort: 0.20 (neutral)
Signal:(63.243) Neutral

Milestone Pharmaceuticals Korrelasjon

10 Mest positive korrelasjoner
RMRM0.881
GNUS0.874
AADI0.874
TANH0.862
CIZN0.834
MOTS0.833
HYW0.832
SEV0.828
FCACU0.819
SNCE0.818
10 Mest negative korrelasjoner
LMRK-0.927
QADA-0.899
EYEG-0.852
AGFS-0.846
APEN-0.84
MGYR-0.837
STTK-0.823
INBX-0.811
BKCC-0.806
MBINO-0.804

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Milestone Pharmaceuticals Korrelasjon - Valuta/Råvare

The country flag -0.01
( neutral )
The country flag 0.20
( neutral )
The country flag 0.00
( neutral )
The country flag -0.33
( neutral )
The country flag 0.52
( weak )
The country flag -0.54
( weak negative )

Milestone Pharmaceuticals Økonomi

Annual 2023
Omsetning: $1.00M
Bruttogevinst: $402 000 (40.20 %)
EPS: $-1.390
FY 2023
Omsetning: $1.00M
Bruttogevinst: $402 000 (40.20 %)
EPS: $-1.390
FY 2022
Omsetning: $5.00M
Bruttogevinst: $4.52M (90.40 %)
EPS: $-1.350
FY 2021
Omsetning: $15.00M
Bruttogevinst: $15.00M (100.00 %)
EPS: $-1.460

Financial Reports:

No articles found.

Milestone Pharmaceuticals

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collaboration agreement with Ji Xing Pharmaceuticals to develop and commercialize etripamil prophylactic and therapeutic uses in humans. The company was incorporated in 2003 and is headquartered in Montréal, Canada.

Om Live Signaler

Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.

Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.